Hayadan > COVID-19
COVID-19
- The Voice of Science website - the Israel National Science Foundation
- February 28, 2024
Researchers used RNA sequencing of individual cells to characterize the ways in which the corona virus spreads in the cells of the body, and in the general population
- Avi Blizovsky
- December 24, 2023
- 10 תגובות
This is according to a comprehensive survey published by the PEW Research Institute. The worst situation is among the voters of the Republican Party, but also among the Democrats, the majority who still show confidence in science is shrinking
- Weizmann Institute
- November 12, 2023
A tweet by Prof. Nir London from the Weizmann Institute of Science grew into an international partnership to find a cure for Corona based on the principles of open science and crowd wisdom. Now the scientists involved are laying the groundwork to deal with the next epidemic
- The Voice of Science website - the Israel National Science Foundation
- October 19, 2023
About two components that help COVID-19 make its proteins and multiply
- Dr. Moshe Nahamani
- October 2, 2023
- No comments
Kariko and Weissman immediately realized that their discovery was of enormous significance for the possible use of messenger RNA in medicine. These important findings were published in 2005, 15 years before the outbreak of the Corona epidemic.
- Avi Blizovsky
- October 2, 2023
- One response
The two, Katalin Kariko and Drew Weissman, were informed about a month ago that they had won the HARVEI Award at the Technion
- Dr. Moshe Nahamani
- July 16, 2023
- No comments
IBM's artificial intelligence model was able to find compounds that bind to different sites on target proteins against the corona disease caused by the covid virus and this without knowing the mechanism of the attachment of the virus to the cell
- Haifa University
- March 12, 2023
- No comments
This is according to a joint study by the Technion and the University of Haifa. In the study, data was collected from 252,858 United Health Insurance policyholders between the ages of 15 and 44, for the period between January 2017 and April 2021
- Tel Aviv University
- September 8, 2022
According to the researchers from Tel Aviv University, spot treatment with antibodies and their delivery to the body in high concentration can serve as an effective substitute for RNA vaccines, especially for at-risk populations and people with a weakened immune system
- Avi Blizovsky
- July 29, 2022
- One response
One of the ideas for saving humanity in the event of a deadly epidemic or other major global disaster is to create a safe haven where some people can survive
- Tel Aviv University
- July 10, 2022
This is according to a study by Tel Aviv University, Ben Gurion University and the Ministry of Health, which included 40,000 residents in the "Protection of Fathers and Mothers" program
- The Technion
- July 2, 2022
The reason for the award - "an extraordinary biotechnological achievement that testifies to the importance of science" * At the same time, Borla won the Genesis Prize worth one million dollars which is an advantage for the establishment of a museum for the heritage of the Jews of Thessaloniki in the city * including a transcript of Borla's speech at the ceremony
- Avi Blizovsky
- June 27, 2022
- 3 תגובות
The researchers estimate that about 600 per thousand additional people could be saved if the World Health Organization's goal of vaccinating 40% of the population in each country with two or more doses by the end of 2021 was achieved.
- Tel Aviv University
- June 24, 2022
- 3 תגובות
Evolutionary mapping in chronic corona patients reveals the path to the formation of a variant * In immunosuppressed patients, chronic corona disease sometimes develops. The study found that the damaged immune system of these patients fails to eliminate the virus, which, on the other hand, develops over time mutations that confer resistance to antibodies and are more contagious
- The science service
- June 11, 2022
- No comments
Such a vaccine can provide a significant advantage, especially in developing countries, in that its administration does not require medical skill, the logistics for its transportation are simpler and cheaper and should even cover a wide range of variants
- The Voice of Science website - the Israel National Science Foundation
- May 17, 2022
About shaping memories and historical epidemics and how the corona epidemic will be remembered
- Science site The Conversation
- May 6, 2022
- One response
More precisely a cognitive decline such as that which occurs between the ages of 50 and 70, which is also equivalent to ten IQ points
- Science site The Conversation
- March 26, 2022
- 8 תגובות
A new brain imaging study found that participants who had even mild corona showed an average decrease in the size of the entire brain.
- Weizmann Institute
- March 3, 2022
Critically ill, recovering or vaccinated - how do the antibodies to corona that each of the groups produces differ and what are the unique characteristics of the antibodies acquired following vaccination
- Dr. Moshe Nahamani
- February 17, 2022
- One response
A team of researchers succeeded in developing innovative nanoparticles that could be used as "molecular traps" targeting the corona virus while binding to the virus and thereby preventing it from acting
- Avi Blizovsky
- February 6, 2022
- 3 תגובות
- Dr. Moshe Nahamani
- January 26, 2022
- One response
- Science site The Conversation
- January 19, 2022
- 5 תגובות
This is what a British medical microbiologist warns based on comprehensive studies from all over the world. She calls on the decision-makers not to shorten the isolation and release into the environment people who may be infected * Her findings are also relevant to Israel, which is about to adopt the procedure that began in the USA
- Dr. Moshe Nahamani
- December 31, 2021
- One response
Researchers have succeeded in developing a rapid detection test for the corona virus, this in order to meet the challenge of finding new variants and global containment of the epidemic
- Science site The Conversation
- December 20, 2021
- 6 תגובות
It seems that leumicron has the ability to bypass existing immunity, either from a vaccine or in convalescents. However, it seems that it is more difficult to cause a serious illness in those vaccinated with the booster shot, so experts recommend getting vaccinated as soon as possible